Augmenting the research portfolio and elevating its prominence through enhanced quality and impact.
These facilities offer a wide range of services, including cutting-edge technologies and high-end instrumentation coupled with technical support for research.
Coronavirus (COVID-19) Update: SMHS Research Re-Start PlansVisit GW SMHS ON CAMPUS Policies and Guidelines website
With a five-year, $6.2 million project program grant, researchers at the George Washington University School of Medicine and Health Sciences have begun to crack open the mystery behind 22q11.2 Deletion Syndrome, or DiGeorge Syndrome.
More than 150 MD program students presented abstracts, poster sessions, and selected oral presentations on a range of disciplines, such as clinical and translational science, clinical public health, and medical education-related research.
The GW School of Medicine and Health Sciences has been selected to serve as one of 24 participating sites for the Phase 2 clinical trial to evaluate additional COVID-19 booster shots in adults, including multiple vaccines based on viral variants such as Delta and Omicron. The trial aims to understand if different vaccine regimens – prototype and variant vaccines alone and in combinations – can broaden immune responses in adults who already have received a primary vaccination series and a first booster shot.
